- Home
- Publications
- Publication Search
- Publication Details
Title
Steroidogenic cytochrome P450 17A1 structure and function
Authors
Keywords
Cytochrome P450 17A1, Mechanism, Crystallography, Prostate, Cancer, Cushing's syndrome
Journal
MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 528, Issue -, Pages 111261
Publisher
Elsevier BV
Online
2021-03-27
DOI
10.1016/j.mce.2021.111261
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment
- (2020) Ravi A. Madan et al. Clinical Genitourinary Cancer
- Slow tight binding inhibition of CYP17A1 by abiraterone redefines its kinetic selectivity and dosing regimen
- (2020) Eleanor Jing Yi Cheong et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Reduction Potentials of P450 Compounds I and II: Insight into the Thermodynamics of C–H Bond Activation
- (2019) Kaustuv Mittra et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Conformational selection dominates binding of steroids to human cytochrome P450 17A1
- (2019) F. Peter Guengerich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The “backdoor pathway” of androgen synthesis in human male sexual development
- (2019) Walter L. Miller et al. PLOS BIOLOGY
- CYP17A1 Maintains the Survival of Glioblastomas by Regulating SAR1-Mediated Endoplasmic Reticulum Health and Redox Homeostasis
- (2019) Lin et al. Cancers
- Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
- (2019) Meghan A. Rice et al. Frontiers in Oncology
- Biomarkers for prostate cancer: prostate-specific antigen and beyond
- (2019) Michael J. Duffy CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Quantum-Mechanical/Molecular-Mechanical Studies of CYP11A1-Catalyzed Biosynthesis of Pregnenolone from Cholesterol Reveal a C–C Bond Cleavage Reaction That Occurs by a Compound I-Mediated Electron Transfer
- (2019) Hao Su et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Human P450 CYP17A1: Control of Substrate Preference by Asparagine 202
- (2018) Michael C. Gregory et al. BIOCHEMISTRY
- Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer
- (2018) Aditya Bardia et al. BREAST CANCER RESEARCH AND TREATMENT
- Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2
- (2018) Charlie Fehl et al. JOURNAL OF MEDICINAL CHEMISTRY
- Human Cytochrome CYP17A1: The Structural Basis for Compromised Lyase Activity with 17-Hydroxyprogesterone
- (2018) Piotr J. Mak et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Role of Androgen Receptor in Prostate Cancer: A Review
- (2018) Kazutoshi Fujita et al. World Journal of Mens Health
- Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1
- (2017) Eric Gonzalez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inherent steroid 17α,20-lyase activity in defunct cytochrome P450 17A enzymes
- (2017) Eric Gonzalez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer
- (2017) John D. Norris et al. JOURNAL OF CLINICAL INVESTIGATION
- Androgen biosynthesis during minipuberty favors the backdoor pathway over the classic pathway: Insights into enzyme activities and steroid fluxes in healthy infants during the first year of life from the urinary steroid metabolome
- (2017) Nasser A. Dhayat et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome
- (2017) Nesa Marti et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma
- (2017) J-Y Chuang et al. Oncogenesis
- Evidence that cytochrome b5 acts as a redox donor in CYP17A1 mediated androgen synthesis
- (2016) Ruchia Duggal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cytochrome b5 Activates the 17,20-Lyase Activity of Human Cytochrome P450 17A1 by Increasing the Coupling of NADPH Consumption to Androgen Production
- (2016) Hwei-Ming Peng et al. BIOCHEMISTRY
- Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer
- (2016) Murtuza Rampurwala et al. INVESTIGATIONAL NEW DRUGS
- Mechanism of 17α,20-Lyase and New Hydroxylation Reactions of Human Cytochrome P450 17A1
- (2016) Francis K. Yoshimoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer
- (2015) J. O'Shaughnessy et al. ANNALS OF ONCOLOGY
- Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency
- (2015) Adina F. Turcu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5
- (2015) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- The diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1)
- (2015) Francis K. Yoshimoto et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
- (2015) Fred Saad et al. LANCET ONCOLOGY
- COPII-Dependent ER Export: A Critical Component of Insulin Biogenesis and β-Cell ER Homeostasis
- (2015) Jingye Fang et al. MOLECULAR ENDOCRINOLOGY
- Unveiling the crucial intermediates in androgen production
- (2015) Piotr J. Mak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors
- (2014) Stephen W. Rafferty et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Human Cytochrome P450 17A1 Conformational Selection
- (2014) D. Fernando Estrada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structures of Human Steroidogenic Cytochrome P450 17A1 with Substrates
- (2014) Elyse M. Petrunak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A-ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone
- (2014) Mariana Garrido et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Mechanism of the Third Oxidative Step in the Conversion of Androgens to Estrogens by Cytochrome P450 19A1 Steroid Aromatase
- (2014) Francis K. Yoshimoto et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Active site proton delivery and the lyase activity of human CYP17A1
- (2013) Yogan Khatri et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Structural Diversity of Eukaryotic Membrane Cytochrome P450s
- (2013) Eric F. Johnson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Model of the Membrane-bound Cytochromeb5-Cytochrome P450 Complex from NMR and Mutagenesis Data
- (2013) Shivani Ahuja et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Substrate-modulated Cytochrome P450 17A1 and Cytochromeb5Interactions Revealed by NMR
- (2013) D. Fernando Estrada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Kinetic Solvent Isotope Effect in Human P450 CYP17A1-Mediated Androgen Formation: Evidence for a Reactive Peroxoanion Intermediate
- (2013) Michael C. Gregory et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) F. E. Vera-Badillo et al. JNCI-Journal of the National Cancer Institute
- Minor Activities and Transition State Properties of the Human Steroid Hydroxylases Cytochromes P450c17 and P450c21, from Reactions Observed with Deuterium-Labeled Substrates
- (2012) Francis K. Yoshimoto et al. BIOCHEMISTRY
- Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys
- (2012) Masuo Yamaoka et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001
- (2012) Natasha M. DeVore et al. NATURE
- DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway
- (2012) M A Kang et al. Cell Death & Disease
- Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma
- (2012) Koji Yoshimoto et al. Frontiers in Oncology
- Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer
- (2011) Tomohiro Kaku et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
- (2011) Jessica L L Robinson et al. EMBO JOURNAL
- The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
- (2011) Walter L. Miller et al. ENDOCRINE REVIEWS
- Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
- (2011) Nils Krone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer
- (2011) Gerhardt Attard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Increased Activation of the Alternative “Backdoor” Pathway in Patients with 21-Hydroxylase Deficiency: Evidence from Urinary Steroid Hormone Analysis
- (2011) Clemens Kamrath et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats
- (2011) João Paulo Gabriel Camporez et al. JOURNAL OF PHYSIOLOGY-LONDON
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b5
- (2010) Sang-Choul Im et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Molecular Modeling on Inhibitor Complexes and Active-Site Dynamics of Cytochrome P450 C17, a Target for Prostate Cancer Therapy
- (2010) Shozeb M. Haider et al. JOURNAL OF MOLECULAR BIOLOGY
- A single amino acid residue, Ala 105, confers 16α-hydroxylase activity to human cytochrome P450 17α-hydroxylase/17,20 lyase
- (2010) Amanda C. Swart et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- A review of mechanistic studies on aromatase (CYP19) and 17α-hydroxylase-17,20-lyase (CYP17)
- (2010) Muhammad Akhtar et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
- (2009) Francesca De Amicis et al. BREAST CANCER RESEARCH AND TREATMENT
- The Role of Androgen Receptor Mutations in Prostate Cancer Progression
- (2009) G. Brooke et al. CURRENT GENOMICS
- Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor
- (2008) Djuana M. E. Harvell et al. BREAST CANCER RESEARCH AND TREATMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started